These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6411514)

  • 21. Sensitivity of TSTA and species-specific cell membrane antigens of tumor cells to glutaraldehyde treatment.
    Kluchareva TE; Matveeva VA; Deichman GI
    Neoplasma; 1978; 25(3):273-8. PubMed ID: 98720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity of tumor cells modified by trinitrobenzene suflonic acid (TNBS).
    Kedar E; Unger E; Galili N; Klein G; Asjo B; Bonavida B; Naor D
    Prog Clin Biol Res; 1976; 9():109-21. PubMed ID: 1030796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor activity of 7-n-(p-hydroxyphenyl)-mitomycin C in experimental tumor systems.
    Imai R; Morimoto M; Marumo H; Kobayashi T; Tsuruo T; Inaba M; Tsukagoshi S; Sakurai Y
    Gan; 1981 Dec; 72(6):944-9. PubMed ID: 6804296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of the murine mixed leukocyte reaction: optimal proliferation of responders requires activation of stimulators.
    Roy C; Lapp WS; Brown DL; Kaplan JG
    Immunobiology; 1985 Mar; 169(2):103-15. PubMed ID: 3158588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the cellular immune response to simian virus 40 tumor cells in tumor-bearing and tumor-immune mice by concanavalin A.
    Davis S; Boone CW
    J Natl Cancer Inst; 1975 Feb; 54(2):435-8. PubMed ID: 163333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concanavalin A-inducible suppressor cells in regional lymph nodes of cancer patients.
    Catalona WJ; Ratliff TL; McCool RE
    Cancer Res; 1979 Nov; 39(11):4372-7. PubMed ID: 159124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K; Oka T; Morimoto M
    Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentiation of concanavalin A-bound L1210 vaccine in vivo by chemotherapeutic agents.
    Kataoka T; Kobayashi H; Sakurai Y
    Cancer Res; 1978 May; 38(5):1202-7. PubMed ID: 639053
    [No Abstract]   [Full Text] [Related]  

  • 29. Transfer of concanavalin A between responding lymphocytes and syngeneic stimulating cells in cell-mediated mitogenic response.
    Ozato K; Ebert JD
    J Immunol; 1978 Mar; 120(3):788-95. PubMed ID: 305446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC; Prager MD
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-specific immune responsiveness of the tumor-bearing host.
    Burk MW; Yu S; McKhann CF
    Isr J Med Sci; 1976; 12(4-5):360-8. PubMed ID: 939694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.
    Mukherjee S; Ahmed A; Nandi D
    J Leukoc Biol; 2005 Jul; 78(1):144-57. PubMed ID: 15788440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of glutaraldehyde fixation on the immunogenicity of allogeneic lymphoid and tumour cells.
    Milton JD
    Immunology; 1980 Nov; 41(3):715-21. PubMed ID: 6780448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for the functional binding in vivo of tumor rejection antigens to antigen-presenting cells in tumor-bearing hosts.
    Shimizu J; Zou JP; Ikegame K; Katagiri T; Fujiwara H; Hamaoka T
    J Immunol; 1991 Mar; 146(5):1708-14. PubMed ID: 1993850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blastogenic response of spleen cells from C1300 neuroblastoma-bearing mice to tumor cells or soluble and insoluble tumor antigens.
    Sugimoto T; Sawada T; Tozawa M; Kusunoki T; Kishida T
    Gan; 1979 Jun; 70(3):327-36. PubMed ID: 157310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective elimination of hepatic natural killer T cells with concanavalin A improves liver regeneration in mice.
    Huang W; Dong Z; Wei H; Ding C; Sun R; Tian Z
    Liver Int; 2006 Apr; 26(3):339-45. PubMed ID: 16584397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of mitomycin C alone and in combination with X-rays on EMT6 mouse mammary tumors in vivo.
    Rockwell S
    J Natl Cancer Inst; 1983 Oct; 71(4):765-71. PubMed ID: 6413743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Xenogenization of a mouse lung carcinoma (3LL) by transfection with an allogeneic class I major histocompatibility complex gene (H-2Ld).
    Itaya T; Yamagiwa S; Okada F; Oikawa T; Kuzumaki N; Takeichi N; Hosokawa M; Kobayashi H
    Cancer Res; 1987 Jun; 47(12):3136-40. PubMed ID: 3107804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergy between low-dose chemotherapy and immunotherapy in mouse L1210 leukemia.
    Relyveld EH; Bizzini B; Ophir R; Ben-Efraim S
    Cancer Treat Rep; 1987 Mar; 71(3):241-6. PubMed ID: 3102055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between concanavalin A-induced agglutinability of murine leukemia cells and their propensity to form heterotypic aggregates with syngeneic lymphoid cells.
    Phondke GP; Madyastha KR; Madyastha PR; Barth RF
    J Natl Cancer Inst; 1981 Apr; 66(4):643-7. PubMed ID: 6939911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.